Delivery Order SPE2DB22D1002-SPE2DB25FKWG0
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,250.23 firm-fixed-price delivery order is for the procurement of OPZELURA 1.5% cream, a prescription pharmaceutical product. The award has an ultimate completion date of November 7, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,555.32 contract is for the delivery of OPZELURA 1.5% Cream, a prescription pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,217.78 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a completion date of November 27, 2024 and does not include any set-aside requirements, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,187.36 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,094.53 Firm Fixed Price Delivery Order contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a completion date of September 25, 2024 and does not utilize any set-aside requirements, indicating open competition.
AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.30 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of December 27, 2024.
AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,557.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 24, 2024, and is structured as a firm fixed-price agreement. The award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.44 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating open competition.
The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of a pharmaceutical product, OPZELURA 1.5% Cream, with a ceiling value of $9,000.31 and a completion date of November 21, 2023. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award, valued at $1,290.75, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of April 25, 2024.
This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...